CYTOSORBENTS CORPORATION - COMMON STOCK

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

04 Mar 2025 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

26 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

25 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOSORBENTS CORPORATION - COMMON STOCK

14 Feb 2025 12:29:08 By NetDania Notify

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

13 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

06 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

03 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Rights Offering Begins

23 Dec 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Announces Rights Offering

09 Dec 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference

26 Nov 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

11 Nov 2024 04:30:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results

07 Nov 2024 13:05:02 By Nasdaq GlobeNewswire

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

04 Nov 2024 04:00:00 By Nasdaq GlobeNewswire

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

22 Oct 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results

17 Oct 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

01 Oct 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

27 Aug 2024 04:00:00 By Nasdaq GlobeNewswire

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

13 Aug 2024 13:19:55 By Nasdaq GlobeNewswire

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

13 Aug 2024 13:18:28 By Nasdaq GlobeNewswire